Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical Trial

Sprague

2021

JAMA

174

115

ImportanceAcne vulgaris is an inflammatory disease of the pilosebaceous unit of the skin that primarily involves the face and trunk and affects approximately 9% of the population worldwide (approximately 85% of individuals aged 12-24 years, and approximately 50% of patients aged 20-29 years). Acne vulgaris can cause permanent physical scarring, negatively affect quality of life and self-image, and has been associated with increased rates of anxiety, depression, and suicidal ideation.ObservationsAcne vulgaris is classified based on patient age, lesion morphology (comedonal, inflammatory, mixed, nodulocystic), distribution (location on face, trunk, or both), and severity (extent, presence or absence of scarring, postinflammatory erythema, or hyperpigmentation). Although most acne does not require specific medical evaluation, medical workup is sometimes warranted. Topical therapies such as retinoids (eg, tretinoin, adapalene), benzoyl peroxide, azelaic acid, and/or combinations of topical agents are first-line treatments. When prescribed as a single therapy in a randomized trial of 207 patients, treatment with tretinoin 0.025% gel reduced acne lesion counts at 12 weeks by 63% compared with baseline. Combinations of topical agents with systemic agents (oral antibiotics such as doxycycline and minocycline, hormonal therapies such as combination oral contraception [COC] or spironolactone, or isotretinoin) are recommended for more severe disease. In a meta-analysis of 32 randomized clinical trials, COC was associated with reductions in inflammatory lesions by 62%, placebo was associated with a 26% reduction, and oral antibiotics were associated with a 58% reduction at 6-month follow-up. Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress.Conclusions and RelevanceAcne vulgaris affects approximately 9% of the population worldwide and approximately 85% of those aged 12 to 24 years. First-line therapies are topical retinoids, benzoyl peroxide, azelaic acid, or combinations of topicals. For more severe disease, oral antibiotics such as doxycycline or minocycline, hormonal therapies such as combination oral conceptive agents or spironolactone, or isotretinoin are most effective.

Section: Methodsmentioning

confidence: 99%

Management of Acne Vulgaris

Sprague

2021

JAMA

174

115

Polymers and Polymer Composites

“…A clinical trial conducted in 2015 where Tretinoin Nanogel 0.025% as compared to its Conventional Gel 0.025% proved Tretinoin nanogel to be more effective and better tolerated. 137 Tretinoin incorporated in solid lipid nanoparticles showed better-sustained release, stability, and protection from degradation. The studies showed that chitosan solid lipid nanoparticles combined with Tretinoin resulted in an efficient topical treatment for psoriasis.…”

Section: Nanogels As Carriers For Known Active Drugsmentioning

confidence: 97%

Review on nanogels and their applications on dermal therapy

Botha,

Mushonga,

Onani

2023

A nanogel is a cross-linked nano-sized, a three-dimensional network of hydrophilic polymers with an ability to swell by holding large amount of water while maintaining the structure due to chemical or physical cross-linking of individual polymer chains. Nanogels can be made up of synthetic and/or natural polymers resulting in a cationic, anionic, or neutral system depending on the bound groups’ charges. Currently, these materials are receiving tremendous attention in research due to their properties. They are extensively investigated as carriers in the biomedical field. At present, there is an expansion of research into dermatologic treatment due to a critical need for new treatment options to treat skin diseases. The skin itself provides a natural barrier against particle penetration for topical delivery. However, it also offers a potential approach for the delivery of therapeutics, especially in diseased skin via the openings of hair follicles. Recent innovation might be achieved in the field of dermatological treatment with improvement in the dermal localization of bio-actives into the affected skin region. This report looks at what has been done in the investigation of nanogels as drug carriers for topical therapy.

“…As a result, most topical dosage forms available on the market today have poor penetration capabilities, leading to limited therapeutic benefits. 38 The difficulties of achieving adequate medication absorption via the skin using topical formulations emphasize the need for novel drug delivery technologies, such as NH. Because of their controlled release, increased penetration, and protection of the loaded pharmaceuticals, NH have the potential to improve drug delivery via the skin.…”

Section: Polymeric Nanohydrogelsmentioning

confidence: 99%

Polymeric Nanohydrogel in Topical Drug Delivery System

Yuniarsih,

Chaerunisaa,

Elamin

et al. 2024

IJN

Nanohydrogels (NH) are biodegradable polymers that have been extensively studied and utilized for various biomedical applications. Drugs in a topical medication are absorbed via the skin and carried to the intended location, where they are metabolized and eliminated from the body. With a focus on their pertinent contemporary treatments, this review aims to give a complete overview of recent advances in the creation and application of polymer NH in biomedicine. We will explore the key features that have driven advances in nanotechnology and discuss the significance of nanohydrogel-based formulations as vehicles for delivering therapeutic agents topically. The review will also cover the latest findings and references from the literature to support the advancements in nanotechnological technology related to the preparation and application of NH. In addition, we will also discuss the unique properties and potential applications of NH as drug delivery systems (DDS) for skin applications, underscoring their potential for effective topical therapeutic delivery. The challenge lies in efficiently delivering drugs through the skin’s barrier to specific areas with high control. Environmentally sensitive systems, like polymer-based NH, show promise in treating dermatological conditions. Polymers are pivotal in developing these drug delivery systems, with NH offering advantages such as versatile drug loading, controlled release, and enhanced skin penetration.